About this trial
The success of opioid treatment in terminally ill cancer patients set the stage for extending the same treatment principles to the treatment of all chronic pain conditions including chronic non-cancer pain and chronic pain in cancer, where survival and long-standing chronic disease trajectories are getting more prevalent due to increasing survival rates. In this context, opioid misuse as such has been highly neglected - especially in palliative care, but also in cancer pain management in general. Previous studies have explored the literature on opioid misuse among adult cancer patients, noting that the available evidence is still in its early stages. Limited prospective studies with a wide range of definitions and methodologies for assessing misuse exist. Therefore, it seems highly relevant and justified to study the prevalence of opioid misuse risk in patients with cancer. The hypothesis of this study is that opioid misuse is not uncommon in Danish patients in treatment with opioids for cancer-related pain. Thus, the prevalence of opioid misuse risk among patients with cancer in Danish palliative care units will be investigate.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Outpatients ≥ 18 years,
patients who are treated with opioids due to cancer-related pain.
Disqualifiers
Patients who do not master the Danish language in speech and writing,
Patients who have severe cognitive dysfunction,
Patients who are not treated with opioids,
Patients who refused to participate in the study.
Trial population
Patients will be recruited from Section of Palliative Medicine at Rigshospitalet. Patients can participate if ≥ 18 years and able to communicate in Danish.
Trial design
Other
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Pain Medication Questionnaire (PMQ)
PMQ consists of 26 questions assesses the risk of opioid abuse in people with non-oncological chronic pain. The answers are given on a 5-point Likert scale. Total score varies between 0 and 104 points.
Opioid Risk Tool (ORT)
ORT consists of a 5-question screening instrument assessing the risk for opioid abuse among individuals prescribed opioids for treatment of chronic pain.
Secondary outcomes
Pain diagnosis
Categories: nociceptive somatic, nociceptive visceral, neuropathic, nociplastic, nociceptive +somatic (mixed).
Pain duration
In months.
Pain localization
Categories: head/face/mouth/neck, up limbs, lower limbs, thorax, abdomen, low back/gluteus/coccyx/pelvis.
Pain intensity
Numerical scale from 0 (no pain) to 10 (worst pain).
Other outcomes
Sex
Categories male, female.
Age
Complete years in number.
Marital status
Categories; single (unmarried), married, cohabitating, separated/divorced, widow/widower.
Education status
Categories, basic school, upper secondary or vocational school, higher education.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.